Abaloparatide

Abaloparatide is a PTH1 receptor agonist researched for stimulation of bone formation and improvement of bone quality. Studies indicate it may preferentially activate anabolic bone pathways, potentially reducing fracture risk. This peptide is investigated for its bone-building properties in osteoporosis research.